Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antiplatelet medications in the secondary prevention of ischemic stroke.

× No keyword cloud information.

12 in total

1. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.

Authors: J P Mohr; J L Thompson; R M Lazar; B Levin; R L Sacco; K L Furie; J P Kistler; G W Albers; L C Pettigrew; H P Adams; C M Jackson; P Pullicino
Journal: N Engl J Med Date: 2001-11-15 Impact factor: 91.245

2. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

Authors: Steven R Steinhubl; Peter B Berger; J Tift Mann; Edward T A Fry; Augustin DeLago; Charles Wilmer; Eric J Topol
Journal: JAMA Date: 2002-11-20 Impact factor: 56.272

3. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Authors: S Yusuf; F Zhao; S R Mehta; S Chrolavicius; G Tognoni; K K Fox
Journal: N Engl J Med Date: 2001-08-16 Impact factor: 91.245

4. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.

Authors: H C Diener; L Cunha; C Forbes; J Sivenius; P Smets; A Lowenthal
Journal: J Neurol Sci Date: 1996-11 Impact factor: 3.181

5. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors:
Journal: Lancet Date: 1996-11-16 Impact factor: 79.321

6. Controlled trial of aspirin in cerebral ischemia.

Authors: W S Fields; N A Lemak; R F Frankowski; R J Hardy
Journal: Stroke Date: 1977 May-Jun Impact factor: 7.914

7. A randomized trial of aspirin and sulfinpyrazone in threatened stroke.

Authors:
Journal: N Engl J Med Date: 1978-07-13 Impact factor: 91.245

8. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.

Authors: Hans-Christoph Diener; Julien Bogousslavsky; Lawrence M Brass; Claudio Cimminiello; Laszlo Csiba; Markku Kaste; Didier Leys; Jordi Matias-Guiu; Hans-Jürgen Rupprecht
Journal: Lancet Date: 2004 Jul 24-30 Impact factor: 79.321

Review 9. Cochrane review: dipyridamole for preventing major vascular events in patients with vascular disease.

Authors: E L L M De Schryver; A Algra; J van Gijn
Journal: Stroke Date: 2003-07-10 Impact factor: 7.914

10. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.

Authors: M G Bousser; E Eschwege; M Haguenau; J M Lefaucconnier; N Thibult; D Touboul; P J Touboul
Journal: Stroke Date: 1983 Jan-Feb Impact factor: 7.914